Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krech

Showing results (381-390 of 470) with videos related to

Pageof 47
Sort By:
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2022
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of PathologyAnsgar W Lohse, Marcial Sebode, Prithi S Bhathal, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
Plos Genetics|December 21, 2010
Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cellsKarsten Jürchott, Ralf-Jürgen Kuban, Till Krech, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Pageof 47

Showing results (381-390 of 470) with videos related to

Sort By:
Pageof 47
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2022
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of PathologyAnsgar W Lohse, Marcial Sebode, Prithi S Bhathal, et al.
Oncotarget|November 12, 2016
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancerPatrick Lebok, Magdalena Roming, Martina Kluth, et al.
Plos Genetics|December 21, 2010
Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cellsKarsten Jürchott, Ralf-Jürgen Kuban, Till Krech, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Pageof 47